ClinVar Miner

Submissions for variant NM_001145809.2(MYH14):c.5573G>A (p.Arg1858His)

gnomAD frequency: 0.00137  dbSNP: rs11882073
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000215776 SCV000270441 likely benign not specified 2015-05-26 criteria provided, single submitter clinical testing p.Arg1858His in exon 40 of MYH14: This variant is not expected to have clinical significance because it has been identified in 0.5% (52/9586) of African chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs11882073).
PreventionGenetics, part of Exact Sciences RCV000215776 SCV000306876 likely benign not specified criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000215776 SCV000340848 benign not specified 2016-05-03 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000756389 SCV000884185 likely benign not provided 2023-09-13 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000756389 SCV001111258 benign not provided 2025-01-09 criteria provided, single submitter clinical testing
GeneDx RCV000756389 SCV001773051 likely benign not provided 2021-01-22 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.